EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Controversies in the Management of Early-Stage Hodgkin Lymphoma: The Role of Radiation Therapy

Yorleny Vicioso Mora, Christopher R Kelsey

Journal of the National Comprehensive Cancer Network · 2026

DOI: 10.6004/jnccn.2026.7019 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of the National Comprehensive Cancer Network, 2026. Verfasst von Yorleny Vicioso Mora und 1 weiteren Autor:innen. Beteiligte Einrichtung: 1Department of Radiation Oncology, Duke University Medical Center, Durham, NC. Hauptthemen laut MEDLINE: Hodgkin Disease. Die Arbeit nennt 43 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The treatment of early-stage Hodgkin lymphoma is one of oncology’s great success stories. Numerous large randomized trials have tested and refined conventional chemotherapy regimens, optimized radiation therapy (RT) approaches, explored the integration of metabolic imaging such as PET/CT, and are now evaluating novel agents. What was once a fatal disease is now cured in almost all patients. Combined-modality therapy, typically involving a short course of chemotherapy followed by low-dose, highly conformal RT, has emerged as the most effective strategy for achieving durable remissions. Nonetheless, concerns about the long-term toxicities associated with RT have prompted investigations into chemotherapy-only regimens as a potential alternative to combined-modality therapy. To date, neither interim nor postchemotherapy PET/CT imaging has been able to identify patients who can safely omit consolidation RT without compromising efficacy, although additional studies are ongoing. Meanwhile, novel agents such as nivolumab and brentuximab vedotin have significantly advanced the treatment of advanced-stage disease and are now demonstrating promising activity in early-stage Hodgkin lymphoma. In parallel with advances in systemic therapy, radiation technologies have also progressed substantially. Techniques such as proton therapy, intensity-modulated RT, and image-guided RT dramatically reduce radiation exposure to healthy tissues compared with historical approaches, thereby improving the therapeutic ratio. Despite the high cure rates achieved today, clinical trials continue to explore novel and personalized approaches to achieve long-term remission without compromising quality of life.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hodgkin DiseaseHumansNeoplasm StagingCombined Modality TherapyPositron Emission Tomography Computed TomographyTreatment OutcomeDisease ManagementAntineoplastic Combined Chemotherapy Protocols

Autor:innen und Institutionen

  • 1Department of Radiation Oncology, Duke University Medical Center, Durham, NC.

Zitieren

APA

Vicioso Mora, Y., & Kelsey, C. R. (2026). Controversies in the Management of Early-Stage Hodgkin Lymphoma: The Role of Radiation Therapy. Journal of the National Comprehensive Cancer Network. https://doi.org/10.6004/jnccn.2026.7019

Vancouver

Vicioso Mora Y, Kelsey CR. Controversies in the Management of Early-Stage Hodgkin Lymphoma: The Role of Radiation Therapy. Journal of the National Comprehensive Cancer Network. 2026. doi:10.6004/jnccn.2026.7019

BibTeX
@article{ViciosoMora2026,
  author = {Vicioso Mora, Yorleny and Kelsey, Christopher R},
  title = {Controversies in the Management of Early-Stage Hodgkin Lymphoma: The Role of Radiation Therapy},
  journal = {Journal of the National Comprehensive Cancer Network},
  year = {2026},
  doi = {10.6004/jnccn.2026.7019}
}
Kostenlos starten →